Follow the HK이노엔 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, HK이노엔 has published 33 insider filings. Market capitalisation: €1,160.1bn. The latest transaction was reported on 1 July 2026 (Other). Among the most active insiders: 국민연금공단. The full history is openly available.
33
Insider Decl.
0
Thresholds
€55,372
9 ops.
Buy Volume
·
14 ops.
Sell Volume
35Σ signal
Buys €55,372· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 10,188 of 26,211 companies
57.4
score / 100
Value
66
Quality
49
FCF yld6.5%
Earn yld6.5%
EV/EBITDA11.1x
ROE3.9%
Gross mgn46%
Net mgn7.1%
Debt/EBITDA3.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
HK이노엔 is a company operating in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development and commercialization of innovative pharmaceutical products.